Tuna Mutis

12PUBLICATIONS
84CO-AUTHORS
Gene and molecular therapyInnate immunityPharmacogenomicsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 08, 2026
Dual targeting of BCMA and GPRC5D with the trispecific antibody ramantamig addresses antigenic heterogeneity in myeloma.

|Jan 29, 2026
Immune biomarkers of increased infection risk in multiple myeloma.

Aintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos

|Nov 03, 2025
Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma.

M R Seefat, D G J Cucchi, L van Boven

|Oct 06, 2025
Cytoskeletal dynamics and mitochondrial rearrangements drive cell fate upon antibody-induced complement activation in DLBCL.

Hilma J van der Horst, Tamás Csikós, Marjolein Quik

|Aug 19, 2025
A T-cell-based metric of immune age predicts outcomes in older patients with myeloma receiving daratumumab-based therapy.

Wassilis S C Bruins, Febe Smits, Carolien Duetz

|Feb 28, 2025
The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy.

Charlotte L B M Korst, Sabrin Tahri, Carolien Duetz

Pageof 2

Frequent Collaborators

6 joint publications

Sonja Zweegman

4 joint publications

Wassilis S C Bruins

4 joint publications

A Vera de Jonge

4 joint publications

Niels W C J van de Donk